| Financial Year |
March 31 2023 |
| Monetary Funds |
455,270,167.04 |
| Held-for-trading Financial Assets |
260,195,639.20 |
| Notes Receivable |
16,611,433.32 |
| Accounts Receivable |
533,643,035.73 |
| Advances to Suppliers |
3,154,203.12 |
| Other Receivables |
8,882,537.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
212,801,283.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
235,659,625.16 |
| Total Current Assets |
1,728,264,089.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
306,410,248.75 |
| Under-construction Projects |
29,230,238.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
71,368,679.17 |
| R&D expenses |
-- |
| Goodwill |
73,613,173.23 |
| Long-Term Deferred and Prepaid Expenses |
8,121,941.81 |
| Deferred Income Tax Assets |
12,724,700.21 |
| Other Non-Current Assets |
40,861,647.56 |
| Sub-Total of Non-Current Assets |
639,018,873.07 |
| Total Assets |
2,367,282,962.11 |
| Short-Term Loans |
50,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
17,859,223.43 |
| Accounts Payable |
216,841,008.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
63,925,741.58 |
| Taxes Payable |
9,534,808.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
23,681,979.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,991,658.84 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
353,766,983.98 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,809,153.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
102,431,261.60 |
| Total Liabilities |
456,198,245.58 |
| Paid-In Capital(Or Share Stock) |
230,171,765.00 |
| Capital Surplus |
1,061,052,161.20 |
| Surplus Reserve |
57,014,361.71 |
| LESS:Treasury Stock |
20,793,150.00 |
| Undistributed Profits |
572,154,074.85 |
| Minority Stockholder's Interest |
11,437,440.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,899,647,275.59 |
| Owner's Equity（Stockholder's Equity） |
1,911,084,716.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,367,282,962.11 |
